Rationale and Design of the GUIDE-IT Study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Yancy, 2013, 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 62, e147, 10.1016/j.jacc.2013.05.019
Lee, 2004, Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000, Am J Med, 116, 581, 10.1016/j.amjmed.2003.11.025
Stafford, 2003, The underutilization of cardiac medications of proven benefit, 1990 to 2002, J Am Coll Cardiol, 41, 56, 10.1016/S0735-1097(02)02670-0
Fiuzat, 2012, Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial, J Am Coll Cardiol, 60, 208, 10.1016/j.jacc.2012.03.023
Fonarow, 2008, Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF, Circ Heart Fail, 1, 98, 10.1161/CIRCHEARTFAILURE.108.772228
Fonarow, 2010, Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF), Circulation, 122, 585, 10.1161/CIRCULATIONAHA.109.934471
Desai, 2012, Home monitoring heart failure care does not improve patient outcomes: looking beyond telephone-based disease management, Circulation, 125, 828, 10.1161/CIRCULATIONAHA.111.031179
Fuat, 2003, Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study, BMJ, 326, 196, 10.1136/bmj.326.7382.196
Cleland, 2005, Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study, J Am Coll Cardiol, 45, 1654, 10.1016/j.jacc.2005.01.050
Whellan, 2005, Metaanalysis and review of heart failure disease management randomized controlled clinical trials, Am Heart J, 149, 722, 10.1016/j.ahj.2004.09.023
Bourge, 2008, Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study, J Am Coll Cardiol, 51, 1073, 10.1016/j.jacc.2007.10.061
Fonarow, 2004, Heart failure disease management programs: not a class effect, Circulation, 110, 3506, 10.1161/01.CIR.0000151101.17629.20
Januzzi, 2006, Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department, Arch Intern Med, 166, 315, 10.1001/archinte.166.3.315
Fonarow, 2007, Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure, J Am Coll Cardiol, 49, 1943, 10.1016/j.jacc.2007.02.037
Anand, 2003, Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT), Circulation, 107, 1278, 10.1161/01.CIR.0000054164.99881.00
McKelvie, 1999, Comparison of candesartan, enalapril, and their combination in congestive heart failure: Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) pilot study: the RESOLVD Pilot Study Investigators, Circulation, 100, 1056, 10.1161/01.CIR.100.10.1056
Frantz, 2005, Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure, Am Heart J, 149, 541, 10.1016/j.ahj.2004.07.036
Tsutamoto, 2001, Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure, J Am Coll Cardiol, 37, 1228, 10.1016/S0735-1097(01)01116-0
Fruhwald, 2007, Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony, Eur Heart J, 28, 1592, 10.1093/eurheartj/ehl505
Masson, 2008, Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial), J Am Coll Cardiol, 52, 997, 10.1016/j.jacc.2008.04.069
Shah, 2011, The STARBRITE trial: a randomized, pilot study of B-type natriuretic peptide-guided therapy in patients with advanced heart failure, J Card Fail, 17, 613, 10.1016/j.cardfail.2011.04.012
Troughton, 2000, Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations, Lancet, 355, 1126, 10.1016/S0140-6736(00)02060-2
Lainchbury, 2009, N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial, J Am Coll Cardiol, 55, 53, 10.1016/j.jacc.2009.02.095
Pfisterer, 2009, BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial, JAMA, 301, 383, 10.1001/jama.2009.2
Januzzi, 2011, Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction, J Am Coll Cardiol, 58, 1881, 10.1016/j.jacc.2011.03.072
Berger, 2010, N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure: a 3-arm, prospective, randomized pilot study, J Am Coll Cardiol, 55, 645, 10.1016/j.jacc.2009.08.078
Jourdain, 2007, Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study, J Am Coll Cardiol, 49, 1733, 10.1016/j.jacc.2006.10.081
Persson, 2010, Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT-proBNP Guided Management of Heart Failure—SIGNAL-HF (Swedish Intervention study–Guidelines and NT-proBNP AnaLysis in Heart Failure), Eur J Heart Fail, 12, 1300, 10.1093/eurjhf/hfq169
Felker, 2009, Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials, Am Heart J, 158, 422, 10.1016/j.ahj.2009.06.018
Januzzi, 2012, The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for use, Arch Cardiovasc Dis, 105, 40, 10.1016/j.acvd.2011.10.007
Masson, 2006, Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data, Clin Chem, 52, 1528, 10.1373/clinchem.2006.069575
Masson S, Latini R, Carbonieri E, et al. The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial. Eur J Heart Fail 2010,12:338–47.
Hauck, 1998, Should we adjust for covariates in nonlinear regression analyses of randomized trials?, Control Clin Trials, 19, 249, 10.1016/S0197-2456(97)00147-5
Curtis, 2007, Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases, Med Care, 45, S103, 10.1097/MLR.0b013e31806518ac
Konstam, 2007, Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial, JAMA, 297, 1319, 10.1001/jama.297.12.1319
Freidlin, 2010, A general inefficacy interim monitoring rule for randomized clinical trials, Clin Trials, 7, 197, 10.1177/1740774510369019
Haybittle, 1971, Repeated assessment of results in clinical trials of cancer treatment, Br J Radiol, 44, 793, 10.1259/0007-1285-44-526-793
Peto, 1976, Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design, Br J Cancer, 34, 585, 10.1038/bjc.1976.220
Januzzi, 2013, Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management, Circulation, 127, 500, 10.1161/CIRCULATIONAHA.112.120485
Porapakkham, 2010, B-type natriuretic peptide-guided heart failure therapy: a meta-analysis, Arch Intern Med, 170, 507, 10.1001/archinternmed.2010.35
Savarese, 2013, Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials, PloS One, 8, e58287, 10.1371/journal.pone.0058287